Mapping FACT-melanoma quality-of-life scores to EQ-5D health utility weights

Value in Health

Volumn 14, Issue 6, 2011, Pages 900-906

  Askew, Robert L ^a   Swartz, Richard J ^b   Xing, Yan ^a   Cantor, Scott B ^a   Ross, Merrick I ^a   Gershenwald, Jeffrey E ^a   Palmer, J Lynn ^a   Lee, Jeffrey E ^a   Cormier, Janice N ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b RICE UNIVERSITY   (United States)

Author keywords

EQ 5D; functional assessment of cancer therapy; health state utility; melanoma; quality of life; questionnaires

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CONCEPT MAPPING; CONTROLLED STUDY; CORRELATION COEFFICIENT; EQ 5D SCORE; FEMALE; FUNCTIONAL ASSESSMENT OF CANCER THERAPY MELANOMA SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE INDEX; TERTIARY HEALTH CARE; UNITED STATES; VALIDATION PROCESS;

ADULT; AGED; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SOCIOECONOMIC FACTORS;

EID: 80052702522     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2011.04.003     Document Type: Article

References (46)

1. P.N. Butow, A.S. Coates, and S.M. Dunn Psychosocial predictors of survival in metastatic melanoma J Clin Oncol 17 1999 2256 2263 (Pubitemid 29318860)
2. N.R. Maisey, A. Norman, and M. Watson Baseline quality of life predicts survival in patients with advanced colorectal cancer Eur J Cancer 38 2002 1351 1357 (Pubitemid 34686846)
3. A. Coates, V. Gebski, and D. Signorini Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer Australian New Zealand Breast Cancer Trials Group J Clin Oncol 10 1992 1833 1838 (Pubitemid 23064193)
4. A. Montazeri Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008 Health Qual Life Outcomes 7 2009 102
5. A. Coates, D. Thomson, and G.R. McLeod Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma Eur J Cancer 29A 1993 1731 1734 (Pubitemid 23275880)
6. D.F. Roychowdhury, A. Hayden, and A.M. Liepa Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer J Clin Oncol 21 2003 673 678 (Pubitemid 46621902)
7. D. Cella, and C.J. Nowinski Measuring quality of life in chronic illness: the functional assessment of chronic illness therapy measurement system Arch Phys Med Rehabil 83 2002 S10 S17
8. D.F. Cella, D.S. Tulsky, and G. Gray The functional assessment of cancer therapy scale: development and validation of the general measure J Clin Oncol 11 1993 570 579 (Pubitemid 23071057)
9. J.N. Cormier, L. Davidson, and Y. Xing Measuring quality of life in patients with melanoma: development of the FACT-melanoma subscale J Support Oncol 3 2005 139 145 (Pubitemid 40439757)
10. J.N. Cormier, M.I. Ross, and J.E. Gershenwald Prospective assessment of the reliability, validity, and sensitivity to change of the functional assessment of cancer therapy-melanoma questionnaire Cancer 112 2008 2249 2257 (Pubitemid 351628636)
11. C.A. Brauer, A.B. Rosen, and D. Greenberg Trends in the measurement of health utilities in published cost-utility analyses Value Health 9 2006 213 218 (Pubitemid 44126775)
12. R.M. Kaplan, D. Feeny, and D.A. Revicki Methods for assessing relative importance in preference based outcome measures Qual Life Res 2 1993 467 475 (Pubitemid 24035219)
13. J.W. Shaw, J.A. Johnson, and S.J. Coons US valuation of the EQ-5D health states: development and testing of the D1 valuation model Med Care 43 2005 203 220 (Pubitemid 40353904)
14. M.C. Weinstein, J.E. Siegel, and M.R. Gold Recommendations of the panel on cost-effectiveness in health and medicine JAMA 276 1996 1253 1258 (Pubitemid 26337709)
15. K. Stein, A. Fry, and A. Round What value health? A review of health state values used in early technology assessments for NICE Appl Health Econ Health Policy 4 2005 219 228 (Pubitemid 43242210)
16. S.B. Cohen Design strategies and innovations in the medical expenditure panel survey Med Care 41 2003 III5 III12
17. D. Mortimer, and L. Segal Comparing the incomparable? A systematic review of competing techniques for converting descriptive measures of health status into QALY-weights Med Decis Making 28 2008 66 89
18. M.J. Buxton, L.A. Lacey, and B.G. Feagan Mapping from disease-specific measures to utility: an analysis of the relationships between the inflammatory bowel disease questionnaire and Crohn's disease activity index in Crohn's disease and measures of utility Value Health 10 2007 214 220 (Pubitemid 46802279)
19. Y.B. Cheung, L.C. Tan, and P.N. Lau Mapping the eight-item Parkinson's Disease questionnaire (PDQ-8) to the EQ-5D utility index Qual Life Res 17 2008 1173 1181
20. D.S. Brennan, and A.J. Spencer Mapping oral health related quality of life to generic health state values BMC Health Serv Res 6 2006 96
21. M. Yang, D. Dubois, and M. Kosinski Mapping MOS sleep scale scores to SF-6D utility index Curr Med Res Opin 23 2007 2269 2282 (Pubitemid 350246612)
22. E.Q. Wu, P. Mulani, and M.H. Farrell Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D in metastatic hormone-refractory prostate cancer patients Value Health 10 2007 408 414 (Pubitemid 47481112)
23. Y.B. Cheung, J. Thumboo, and F. Gao Mapping the English and Chinese versions of the functional assessment of cancer therapy-general to the EQ-5D utility index Value Health 12 2009 371 376
24. D. Dobrez, D. Cella, and A.S. Pickard Estimation of patient preference-based utility weights from the functional assessment of cancer therapy - general Value Health 10 2007 266 272 (Pubitemid 47077251)
25. R. Rabin, and F. de Charro EQ-5D: a measure of health status from the EuroQol Group Ann Med 33 2001 337 343 (Pubitemid 32675374)
26. J. Brazier, N. Jones, and P. Kind Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire Qual Life Res 2 1993 169 180 (Pubitemid 23203441)
27. M.L. Essink-Bot, P.F. Krabbe, and G.J. Bonsel An empirical comparison of four generic health status measures The Nottingham health profile, the medical outcomes study 36-item short-form health survey, the COOP/WONCA charts, and the EuroQol instrument Med Care 35 1997 522 537 (Pubitemid 127455049)
28. H.M. van Agt, M.L. Essink-Bot, and P.F. Krabbe Test-retest reliability of health state valuations collected with the EuroQol questionnaire Soc Sci Med 39 1994 1537 1544
29. The EuroQol Group EuroQola new facility for the measurement of health-related quality of life Health Policy 16 1990 199 208
30. Functional Assessment of Chronic Illness Therapy Validity and Interpretation (4th ed.) 2008 http://www.FACIT.org [Accessed May 23, 2011]
31. Agency for Healthcare Research and Quality U.S. Valuation of the EuroQol EQ-5D Health States December 2005 http://www.ahrq.gov/rice/EQ5Dproj.htm [Accessed May 23, 2011]
32. D.G. Kleinbaum Applied Regression Analysis and Other Multivariable Methods (3rd ed.) 1998 Duxbury Press Pacific Grove, CA
33. J. Powell Least absolute deviations estimation for the censored regression model J Econometric 25 1984 303 325
34. R.L. Askew, Y. Xing, and J.L. Palmer Evaluating minimal important differences for the FACT-melanoma quality of life questionnaire Value Health 12 2009 1144 1150
35. P. Kind, and S. Macran Eliciting social preference weights for functional assessment of cancer therapy-lung health states Pharmacoeconomics 23 2005 1143 1153 (Pubitemid 41633403)
36. A.S. Pickard, D. Dobrez, and D. Cella Eliciting social preference weights for functional assessment of cancer therapy-lung health states Pharmacoeconomics 24 2006 293 294 (Pubitemid 43374380)
37. Burdon-Jones D, Thomas P, Baker R. Quality of life issues in nonmetastatic skin cancer. Br J Dermatol 162:14751.
38. D. Cornish, C. Holterhues, and L.V. van de Poll-Franse A systematic review of health-related quality of life in cutaneous melanoma Ann Oncol 20 Suppl. 6 2009 vi51 vi58
39. P.M. Fayers, and D. Machin Quality of Life: the Assessment, Analysis, and Interpretation of Patient-Reported Outcomes (2nd ed.) 2007 J. Wiley Chichester; Hoboken, NJ
40. H. Dakin, S. Petrou, and M. Haggard Mapping analyses to estimate health utilities based on responses to the OM8-30 otitis media questionnaire Qual Life Res 19 2010 65 80
41. L.H. Chuang, and P. Kind Converting the SF-12 into the EQ-5D: an empirical comparison of methodologies Pharmacoeconomics 27 2009 491 505
42. J.E. Brazier, Y. Yang, and A. Tsuchiya A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures Eur J Health Econ 11 2010 215 225
43. American Cancer Society Cancer facts & figures 2010 http://www.cancer.org/research/cancerfactsfigures/cancerfactsfigures/ cancer-facts-and-figures-2010 [Accessed May 23, 2011]
44. S. Altekruse, C. Kosary, and M. Krapcho SEER Cancer Statistics Review 2010 National Cancer Institute Bethesda, MD
45. Y. Peeters, and A.M. Stiggelbout Health state valuations of patients and the general public analytically compared: a meta-analytical comparison of patient and population health state utilities Value Health 13 2010 306 309
46. A.S. Pickard, M.P. Neary, and D. Cella Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer Health Qual Life Outcomes 5 2007 70